SNS-301 Monotherapy in High Risk MDS and CMML

Clinical trial NCT04217720 · WITHDRAWN

Trial details

NCT number: NCT04217720
Sponsor: Sensei Biotherapeutics, Inc.
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Myelodysplastic Syndromes Chronic Myelomonocytic Leukemia (CMML)

Start date: 2020-04-01
Primary completion: 2022-01-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.